Pasar al contenido principal

BIOSENSING DEVICES FOR IN VITRO DIAGNOSTICS

PID2022-136453OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exosome Biomarker Profiling Using a Paper-Based Vertical Flow Assay

  • Pallarès-Rusiñol, Arnau|||0000-0001-9990-148X
  • Marfà, Jennifer|||0000-0001-5321-3841
  • Rossi, Rosanna|||0000-0002-3656-2908
  • Martí, Mercè|||0000-0002-1846-0043
  • Pividori, María Isabel|||0000-0002-5266-7873
Exosomes are nanoscale extracellular vesicles that carry valuable biomolecular information. However, their characterization still depends on complex and costly techniques such as flow cytometry. In this study, a paper-based Vertical Flow Assay (VFA) specifically designed for the detection and profiling of exosomes derived from metastatic breast cancer cell lines is presented. The assay operates in an ELISA-like format, targeting exosomal surface proteins (CD9, CD63, CD81, and EGFR1) with specific antibodies and a secondary antibody conjugated to alkaline phosphatase. Upon reaction with the NBT/BCIP substrate, an insoluble indigo precipitate forms on the nitrocellulose membrane, generating a visual signal that can be further quantified by smartphone imaging. The VFA was optimized for membrane type, pore size, and blocking agents, reaching a detection limit of ~6 × 107 exosomes µL-1 in less than 20 min. Comparative studies with bead-based flow cytometry confirmed consistent biomarker expression profiles, demonstrating the reliability of the method. By enabling exosome biomarker profiling in a simplified and low-cost format, this approach provides a promising alternative to flow cytometry and other applications required for exosome characterization.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Competitive magneto enzyme-linked miRNA assay for quantification of microRNAs in exosomes

  • Bernuz, Mireia|||0000-0002-2052-6902
  • Martí, Mercè|||0000-0002-1846-0043
  • Pividori, María Isabel|||0000-0002-5266-7873
MicroRNAs (miRNAs) are non-coding, short RNA sequences involved in gene regulation. Although intracellular molecules, miRNAs are also found in biological fluids, where they serve as promising diagnostic and prognostic biomarkers. In liquid biopsies, miRNAs are protected from RNase activity through association with proteins or as part of the exosomal cargo. Current methods for miRNA detection are technically demanding and resource intensive. Here, we present a competitive magneto enzyme-linked miRNA (ELmiRNA) assay for the direct quantification of miRNAs in exosomes. The assay is based on a DNA scaffold containing two miRNA templates, each hybridized to a complementary double-tagged probe and anchored via a poly(A) tail to oligo(dT)-magnetic particles. Upon incubation with miRNA-containing samples, displacement of the tagged probes occurs, enabling indirect quantification through enzymatic labeling. As proof of concept, miRNA-21 and miRNA-27a, both upregulated in breast cancer, were quantified in MCF-7 and MDA-MB-231 cells and their derived exosomes. The assay achieved limits of detection of 1.5 nM (9.6 pg μL) and 2.7 nM (16.2 pg μL) for miRNA-21 and miRNA-27a, respectively, and yielded 10-30 copies per exosome, in agreement with RT-qPCR validation. The ELmiRNA assay combines sensitivity and selectivity with high-throughput analysis using a routine laboratory filter-based microplate reader. This approach represents a simplified, amplification-free alternative to RT-qPCR for miRNA quantification in exosomes, suitable for routine implementation in standard clinical and research laboratories.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Biotin-specific molecularly imprinted polymers as a biomimetic test line in lateral flow assays

  • Marfà, Jennifer|||0000-0001-5321-3841
  • Valle, Anaixis del|||0000-0001-5587-9081
  • Rovatti Pupin, Rafael|||0009-0009-8834-8557
  • Baró Sastre, Barbara|||0000-0001-7780-1744
  • Bassat, Quique|||0000-0003-0875-7596
  • Taboada Sotomayor, Maria Del Pilar|||0000-0002-6173-7888
  • Pividori, María Isabel|||0000-0002-5266-7873
Lateral flow assays are widely used for rapid diagnostics at the point of care. However, their dependence on biological receptors limits their stability, scalability, and cost-effectiveness. This work demonstrates the use of biotin-specific molecularly imprinted polymers (biotin-MIPs) as synthetic recognition elements in nucleic acid lateral flow (NALF) assays. The biotin-MIPs were synthesized, structurally characterized, and integrated into the nitrocellulose membrane as a test line. Their selective binding affinity was first validated using biotinylated horseradish peroxidase as a model analyte. The platform was then evaluated for the detection of double-tagged PCR amplicons from Escherichia coli labeled with biotin and digoxigenin, achieving a visual detection limit of 2 ng mL-1 and a limit of detection of 1.8 ng mL-1, with no detectable signal in negative controls. Clinical feasibility was further assessed retrospectively using swab specimens collected during routine third-trimester screening (35-37 weeks of gestation) for Group B Streptococcus, a major cause of neonatal sepsis. In this proof-of-concept study, the MIP-based NALF assay showed complete qualitative agreement with the qPCR reference classification and the gold standard microbiological culture, demonstrating the compatibility of this approach with battery-operated portable PCR amplification. Unlike biological receptors, MIPs offer robustness, long-term stability at room temperature, and animal-free scalable production. These features position the MIP-based NALF platform as a cost-effective alternative to antibody-based tests and a promising foundation for next-generation lateral flow diagnostics for the detection of communicable diseases at the point of care.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecularly Imprinted Polymers as Biomimetic Test Zones in Paper-Based Nucleic Acid Assays-Comparing Vertical and Lateral Flow Formats

  • Marfà, Jennifer|||0000-0001-5321-3841
  • Valle, Anaixis del|||0000-0001-5587-9081
  • Taboada Sotomayor, Maria Del Pilar|||0000-0002-6173-7888
  • Pividori, María Isabel|||0000-0002-5266-7873
The development of rapid and sensitive point-of-care nucleic acid tests benefits from robust synthetic recognition elements. Here, a biotin-specific molecularly imprinted polymer (MIP) was synthesized using an optimized protocol and integrated as a biomimetic test zone into two paper-based formats: nucleic acid vertical flow (NAVF) and nucleic acid lateral flow (NALF). Both platforms were evaluated for the detection of double-tagged PCR amplicons from Escherichia coli. NAVF enabled a 3 min visual readout with an LOD of 1.00 × 10-2 ng mL-1. NALF provided a total assay time of <15 min and achieved a visual LOD of 3.17 × 10-2 ng mL-1. Overall, the results demonstrate the versatility of biotin-MIPs as stable synthetic receptors for rapid, low-cost paper-based nucleic acid assays, with NAVF prioritizing speed and design flexibility and NALF prioritizing higher analytical sensitivity.
Dipòsit Digital de Documents de la UAB
Publicación Artículo preliminar (WorkingPaper)

A peripheral proteomic signature of Alzheimer's disease is identified in the plasma extracellular vesicles of mild cognitive impairment patients from a memory clinic, the BIOPEXAL study

  • Capdevila-Bayo, Maria
  • Rossi, Rosanna|||0000-0002-3656-2908
  • De Rojas, Itziar|||0000-0002-2148-381X
  • Puerta, Raquel|||0000-0002-1191-5893
  • Guzman, Laura
  • Carrasco Exposito, Marina|||0000-0001-8301-8000
  • Muñoz-Morales, Álvaro
  • Olivé Roig, Clàudia|||0000-0002-9438-5639
  • Montrreal Navarro, Laura|||0000-0002-0010-645X
  • García-González, Pablo|||0000-0003-0125-5403
  • Bayón-Buján, Paula
  • Miguel-Romero, Andrea
  • Calm, Berta
  • Sotolongo Grau, Oscar|||0000-0002-9679-0670
  • Orellana del Río, Adelina|||0000-0002-0204-1944
  • Tatinya, Natalia
  • Martínez, Marta
  • Alegret, Montserrat|||0000-0002-8164-9500
  • Sanz Cartagena, Mª Pilar
  • Fernández, Mª Victoria
  • Marquié, Marta|||0000-0002-0660-0950
  • Valero, Sergi|||0000-0002-6599-948X
  • Montalban, Xavier|||0000-0002-0098-9918
  • Camins, Antoni|||0000-0002-1229-5956
  • Ramírez-Reveco, Alfredo|||0000-0003-4782-4261
  • Martí, Mercè|||0000-0002-1846-0043
  • Pividori, María Isabel|||0000-0002-5266-7873
  • Boada, Mercè|||0000-0003-2617-3009
  • Ruiz Laza, Agustín|||0000-0003-2633-2495
  • Ettcheto, Miren|||0000-0002-4301-7297
  • Cano, Amanda|||0000-0001-9567-4283
Aims: Alzheimer's disease (AD) is commonly diagnosed when neuronal damage is already established and irreversible. Achieving an accurate differential diagnosis in the preclinical and mild cognitive impairment (MCI) stage is one of the greatest challenges nowadays. Nanotechnological analysis of plasma extracellular vesicles (pEVs) are gaining attention as a promising tool for the early detection of AD pathology. This study aims to evaluate the proteomic profile of pEVs from patients with MCI and AD dementia to explore their potential as AD screening tools. Methods: pEVs were isolated by ultracentrifugation from 144 patients with MCI A-T-, MCI A+T+, and AD dementia. Nanoparticle tracking analysis and cryo-TEM were used to characterize the pEVs. CSF, serum and pEVs proteomics were carried out by using the multiplex PEA technology of Olink® proteomics, Inflammation and Neurology Explore 384 panels (768 proteins). Results: Characterization results showed that isolated plasma fraction corresponded in shape, size and concentration to EVs. Many pEVs neurology proteins involved in AD pathology significantly correlated (r > ± 0.30, p < 0.05) with their CSF homonyms, but not with their serum's. pEVs' proteome correlated with common AD signatures (CSF Aβ42 and pTau181, plasma pTau181, MMSE, NBACE, and Qalb) showing similar patterns to those observed with CSF biomarkers. Several pEVs neurology proteins didn't exhibit differences between the MCI A+T+ and AD dementia groups, whilst they did with MCI A-T-. Proteins in pEVs showed strong correlations with several measures of brain atrophy in MRI. Several neurology pEV proteins predicted conversion from MCI to AD dementia. Moreover, some of these showed a significant diagnostic accuracy of AD pathology. Conclusion: Preliminary results suggest that EVs biomarker signature could reflect AD pathology in the prodromal stages of AD continuum. However, further experiments are still needed for a better understanding of EVs' role in AD development and pathology dissemination.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Rapid and portable molecular test for Mycobacterium sp. based on double-tagging amplification and electrochemical readout

  • Mesas Gómez, Melania|||0000-0002-3297-1077
  • Ropero Gil, Daniel|||0009-0008-2522-1340
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • Pallarès-Rusiñol, Arnau|||0000-0001-9990-148X
  • Ferrer-Dalmau, Jofre|||0000-0002-7415-6222
  • Julián, Esther|||0000-0002-6558-3978
  • Domínguez, José|||0000-0001-7888-0309
  • Pividori, María Isabel|||0000-0002-5266-7873
Tuberculosis (TB) remains one of the leading causes of death worldwide, with Mycobacterium tuberculosis as the main pathogen responsible. Although several rapid molecular tests endorsed by the World Health Organization (WHO) show high accuracy, their implementation in low-resource settings is still limited by cost and infrastructure requirements. In this work, a rapid and portable molecular test was developed for Mycobacterium sp. detection based on double-tagging polymerase chain reaction (PCR) and electrochemical magneto-genosensing. The method enables amplification of mycobacterial DNA using primers targeting the gyrB and IS6110 genes through a double-tagging PCR completed within approximately one hour, followed by electrochemical detection on a handheld, battery-operated device, yielding a measurable current signal within 15 minutes, including single-step incubation and electrochemical readout. The test achieved a limit of detection as low as 117 CFU mL−1 for the gyrB target, comparable to the commercial GeneXpert® MTB/RIF assay, while significantly reducing assay time and equipment needs. Total analysis, including DNA extraction, amplification and detection, was completed within approximately two hours. In addition, comparable electrochemical responses were obtained when PCR amplification was carried out using either a conventional benchtop thermocycler or a portable battery-operated miniPCR device, further supporting the applicability of the method in decentralized and field settings. Overall, this approach combines high sensitivity, portability, and simplicity, offering a promising solution for point-of-care TB diagnosis and adaptable to other infectious diseases by changing the primer sequences.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Improved biosensing of Legionella by integrating filtration and immunomagnetic separation of the bacteria retained in filters

  • Mesas Gómez, Melania|||0000-0002-3297-1077
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • de Araújo, Bárbara Camila
  • Boldrin Zanoni, Maria Valnice|||0000-0002-2296-1393
  • Julián, Esther|||0000-0002-6558-3978
  • Domínguez, José|||0000-0001-7888-0309
  • Pividori, María Isabel|||0000-0002-5266-7873
A novel approach is presented that combines filtration and the direct immunomagnetic separation of the retained bacteria Legionella in filters, for further electrochemical immunosensing. This strategy allows for the separation and preconcentration of the water-borne pathogen from high-volume samples, up to 1000 mL. The limit of detection of the electrochemical immunosensor resulted in 100 CFU mL-1 and improved up to 0.1 CFU mL-1 when the preconcentration strategy was applied in 1 L of sample (103-fold improvement). Remarkably, the immunosensor achieves the limit of detection in less than 2.5 h and simplified the analytical procedure. This represents the lowest concentration reported to date for electrochemical immunosensing of Legionella cells without the need for pre-enrichment or DNA amplification. Furthermore, the study successfully demonstrates the extraction of bacteria retained on different filtering materials using immunomagnetic separation, highlighting the high efficiency of the magnetic particles to pull out the bacteria directly from solid materials. This promising feature expands the applicability of the method beyond water systems for detecting bacteria retained in air filters of air conditioning units by directly performing the immunomagnetic separation in the filters.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mycobacterium detection method combining filtration, immunomagnetic separation, and electrochemical readout in a portable biosensing device

  • Mesas Gómez, Melania|||0000-0002-3297-1077
  • Molina-Moya, Barbara|||0000-0001-5144-2165
  • de Araújo, Bárbara Camila
  • Pallarès-Rusiñol, Arnau|||0000-0001-9990-148X
  • Ferrer-Dalmau, Jofre|||0000-0002-7415-6222
  • Boldrin Zanoni, Maria Valnice|||0000-0002-2296-1393
  • Domínguez, José|||0000-0001-7888-0309
  • Julián, Esther|||0000-0002-6558-3978
  • Pividori, María Isabel|||0000-0002-5266-7873
This study addresses a straightforward and highly sensitive approach for detecting Mycobacterium fortuitum. The method involves a combination of filtration and direct immunomagnetic separation to isolate the bacteria retained on filters for further electrochemical magneto immunosensing in a handheld device. Unlike conventional methods involving pre-enrichment by culturing, this approach employs a simplified preconcentration technique, which includes filtration of large water samples, up to 100 mL, followed by a one-step process of immunomagnetic separation and labeling. After a 60-min, during which the filter with the retained bacteria and all the reagents (including modified magnetic particles and enzymatic conjugates) are incubated, the resulting product is directly drop into a cartridge, capable of performing magnetic actuation and washing. The electrochemical readout is carried out on a portable battery-operated device within 30 seconds. Remarkably, the immunosensor demonstrates an outstanding limit of detection of 5 CFU mL-1 in hemodialysis water processing 100 mL of sample. This achievement is remarkable considering the short and simplified analytical procedure, compared to the traditional isolation and culturing of mycobacteria, which typically takes 2 weeks.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Los exosomas, nuevas herramientas para el diagnóstico de enfermedades no transmisibles en biopsias líquidas

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Peptide-based biosensing approaches for targeting breast cancer-derived exosomes

  • da Fonseca Alves, Rafael|||0000-0002-6319-9817
  • Pallarès-Rusiñol, Arnau|||0000-0001-9990-148X
  • Rossi, Rosanna|||0000-0002-3656-2908
  • Martí, Mercè|||0000-0002-1846-0043
  • Rezende Vaz, Emilia|||0000-0003-1733-9812
  • Gonçalves de Araújo, Thaise
  • Taboada Sotomayor, Maria Del Pilar|||0000-0002-6173-7888
  • Pividori, María Isabel|||0000-0002-5266-7873
Exosomes are nanovesicles present in all the biological fluids, making them attractive as non-invasive biomarkers for diseases like cancer, among many others. However, exosomes are complex to separate and detect, requiring comprehensive molecular characterization for their routine use in diagnostics. This study explores the use of peptides as cost-effective and stable alternatives to antibodies for exosome binding. To achieve that, phage display technology was employed to select peptides with high specificity for target molecules in exosomes. Specifically, a selected peptide was evaluated for its ability to selectively bind breast cancer-derived exosomes. Proteomic analysis identified 38 protein candidates targeted by the peptide on exosome membranes. The binding of the peptide to breast cancer-derived exosomes was successfully demonstrated by flow cytometry and magneto-actuated immunoassays. Furthermore, an electrochemical biosensor was also tested for breast cancer-derived exosome detection and quantification. The peptide demonstrated effective binding to exosomes from aggressive cancer cell lines, offering promising results in terms of specificity and recovery. This research shows potential for developing rapid, accessible diagnostic tools for breast cancer, especially in low-resource healthcare settings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluating smartphone-based optical readouts for immunoassays in human and veterinary healthcare, A comparative study

  • Mesas Gómez, Melania|||0000-0002-3297-1077
  • Julián, Esther|||0000-0002-6558-3978
  • Armengou Ruiz, Lara|||0000-0003-4715-7323
  • Pividori, María Isabel|||0000-0002-5266-7873
Recent advances have significantly enhanced the use of smartphone devices for medical diagnostics. This study uses high-resolution cameras in mobile devices to capture and process bioassay images, enabling the quantification of diverse biomarkers across a range of diagnostic tests conducted on 96-well microplates. The study evaluates the effectiveness of this technology through protein quantification techniques and immunoassays that generate colorimetric responses at specific wavelengths. It includes the assessment of bicinchoninic acid and Bradford protein quantification methods, alongside a conventional immunoassay for detecting mare antibodies in colostrum to monitor foal immunodeficiencies. Further application involves the readout of magneto-actuated immunoassays aimed at quantifying bacteria. The results obtained from benchtop spectrophotometry at 595, 562, and 450 nm are compared with those acquired using a smartphone, which identified color intensities in shades of blue, purple, and yellow. This comparison yields promising correlations for the samples tested, suggesting a high degree of accuracy in the smartphone capability to analyze bioassay outcomes. The analysis via smartphone is facilitated by a specific app, which processes the images captured by the phone camera to quantify color intensities corresponding to different biomarker concentrations. Detection limits of 12.3 and 22.8 μg mL for the bicinchoninic acid assay and 36.7 and 45.4 μg mL for the Bradford are obtained for protein quantification using the spectrophotometer and the smartphone app, respectively. For mare's antibodies in colostrum, the values are 1.14 and 1.72 ng mL, while the detection of E. coli is performed at 2.0 x 10 and 2.9 × 10 CFU mL, respectively. This approach offers further advantages, including wide availability, cost-effectiveness, portability, compared to traditional and expensive benchtop instruments.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Rapid diagnostic test for assessment of cellular immune response in a viral infection as a model

  • Bernuz, Mireia|||0000-0002-2052-6902
  • Porras, Juan Carlos
  • Egri, Natalia|||0000-0001-7698-0672
  • González-Navarro, Europa Azucena|||0000-0003-3310-5557
  • Juan, Manel|||0000-0002-3064-1648
  • Pividori, María Isabel|||0000-0002-5266-7873
  • Martí, Mercè|||0000-0002-1846-0043
The global SARS-CoV-2 pandemic has highlighted the critical importance of evaluating adaptive immunological status in both infected individuals and those who have been vaccinated. While the humoral immune response has been extensively studied, the cellular immune component has not progressed as rapidly due to challenges in developing rapid diagnostic tests for activated T cells. This study introduces a rapid, user-friendly assay aimed at addressing this need by using the early expression of interferon-gamma (IFN-γ) transcripts for rapid and direct evaluation. Using a novel design, this assay measures IFN-γ mRNA rather than its protein levels, thereby significantly shortening the time to result compared to traditional methods. The process involves incubating whole blood with a mixture of Spike and Nucleocapsid peptides, followed by immunomagnetic separation of CD3+ T cells and subsequent double-tagging RT-PCR. A lateral flow assay (LFA) is then used for detection, allowing IFN-γ mRNA levels to be assessed rapidly. Non-stimulated samples are used as controls to establish baseline IFN-γ expression. The intensity of the LFA signals from the stimulated samples is then compared to these baseline values using a smartphone interface. Furthermore, the study includes a time course analysis to monitor the T cell response dynamics over time in infected individuals. This LFA-IFN-γ represents a significant progress in the field of rapid diagnostics, offering a one-day protocol that simplifies testing procedures and is especially suitable for low-resource settings.